Hyperprolactinaemia, drug-induced

E4_HYPERPRO_ADVERSE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 E22.1#

833

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

132

diagram downward connector

Check minimum number of events None

132

diagram downward connector

Include endpoints None

132

diagram downward connector
E4_HYPERPRO_ADVERSE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 E22
Name in latin Hyperprolactinaemia

Summary Statistics

Key figures

All Female Male
Number of individuals 130 114 16
Unadjusted prevalence (%) 0.04 0.07 0.01
Mean age at first event (years) 39.30 37.37 53.07

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits: 0

Survival analyses between endpoints

Plot

before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced